These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24799155)

  • 41. [Myocardial no-reflow phenomenon: recent knowledges].
    Pontecorvo ML; Spaziani C; Montone RA; Cosentino N; Minelli S; Niccoli G
    Recenti Prog Med; 2011 Feb; 102(2):53-7. PubMed ID: 21513120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T2 cardiac magnetic resonance in infarct patients: sideman or leader?
    Garot J; Hovasse T; Unterseeh T; Louvard Y; Morice MC; Piéchaud JF; Garot P
    Arch Cardiovasc Dis; 2009; 102(8-9):595-7. PubMed ID: 19786262
    [No Abstract]   [Full Text] [Related]  

  • 43. Intramyocardial haemorrhage after acute myocardial infarction.
    Betgem RP; de Waard GA; Nijveldt R; Beek AM; Escaned J; van Royen N
    Nat Rev Cardiol; 2015 Mar; 12(3):156-67. PubMed ID: 25403783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
    Zhao XJ; Liu XL; He GX; Xu HP
    Braz J Med Biol Res; 2014 Feb; 47(3):245-51. PubMed ID: 24554037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.
    Tanzilli G; Greco C; Pasceri V; Pelliccia F; Arrivi A; Placanica A; Mangieri E
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):787-93. PubMed ID: 20737584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No-reflow: again prevention is better than treatment.
    Niccoli G; Kharbanda RK; Crea F; Banning AP
    Eur Heart J; 2010 Oct; 31(20):2449-55. PubMed ID: 20837571
    [No Abstract]   [Full Text] [Related]  

  • 47. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
    Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
    Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Predictors of the no-reflow phenomenon after primary percutaneous coronary intervention for acute myocardial infarction].
    Zhao Y; Chen Y; Tian F; Wang C; Hu S; Wang J; Yang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):261-4. PubMed ID: 22381773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does angiographic response to wiring of totally occluded vessels predict outcomes in ST-segment elevation myocardial infarction?
    Ambrose JA; Buhari CF
    JACC Cardiovasc Interv; 2011 Jan; 4(1):63-5. PubMed ID: 21251630
    [No Abstract]   [Full Text] [Related]  

  • 50. The preventive effect of garlicin on a porcine model of myocardial infarction reperfusion no-reflow.
    Li JH; Yang P; Li AL; Wang Y; Shi ZX; Ke YN; Li XL
    Chin J Integr Med; 2014 Jun; 20(6):425-9. PubMed ID: 22539198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.
    Sakata Y; Kodama K; Ishikura F; Komamura K; Hasegawa S; Sakata Y; Hirayama A
    Jpn Circ J; 1997 May; 61(5):455-8. PubMed ID: 9192246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plaque shift and distal embolism in patients with acute myocardial infarction: a volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial.
    Wu X; Maehara A; He Y; Xu K; Oviedo C; Witzenbichler B; Lansky AJ; Dressler O; Parise H; Stone GW; Mintz GS
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):203-9. PubMed ID: 22936619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
    Peng Y; Fu X; Li W; Geng W; Xing K; Ru L; Sun J; Zhao Y
    Coron Artery Dis; 2014 Dec; 25(8):645-52. PubMed ID: 25230304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological and physical prevention and treatment of no-reflow after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Guo AQ; Sheng L; Lei X; Shu W
    J Int Med Res; 2013 Jun; 41(3):537-47. PubMed ID: 23628920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Magro M; Nauta ST; Simsek C; Boersma E; van der Heide E; Regar E; van Domburg RT; Zijlstra F; Serruys PW; van Geuns RJ
    Am J Cardiol; 2012 Mar; 109(5):601-6. PubMed ID: 22177003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of stent overexpansion to the angiographic no-reflow phenomenon in intravascular ultrasound-guided stent implantation for acute myocardial infarction.
    Maekawa Y; Asakura Y; Anzai T; Ishikawa S; Okabe T; Yoshikawa T; Ogawa S
    Heart Vessels; 2005 Feb; 20(1):13-8. PubMed ID: 15700197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of thrombus burden and no-reflow of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of platelet indices.
    Cakici M; Cetin M; Balli M; Akturk E; Dogan A; Oylumlu M; Abus S; Yildiz E; Sungur A; Celiker M
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):709-15. PubMed ID: 24806326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute coronary syndromes: No-reflow--an ominous sign of cardiac dysfunction.
    Magro M; Serruys PW
    Nat Rev Cardiol; 2010 Sep; 7(9):480-2. PubMed ID: 20725104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size.
    Hale SL; Herring MJ; Kloner RA
    J Am Heart Assoc; 2013 Jan; 2(1):e004234. PubMed ID: 23525431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical evaluation of thrombus aspiration combined with tirofiban in patients with acute myocardial infarction with elective percutaneous coronary intervention.
    Liu X; Dong P; Xing S; Wang H; Li Z; Zhang H; Yang X; Wang S; Zhai Q
    J Int Med Res; 2013 Oct; 41(5):1532-40. PubMed ID: 23963850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.